1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Details of endovascular procedures
Variables Values
Platelet function test 
 PRU (SD) 187.7 (67.1)
 Clopidogrel hyporesponder (No.) (%) 23 (34.8)^a
Stent type (No.) (%) 
 LVIS Jr 22 (33.3)
 Neuroform Atlas 44 (66.7)
No. of stents (No.) (%) 
 1 59 (89.4)
 2 7 (10.6)^b
^aModified with cilostazol (100 mg twice daily).
^b Including 6 Y-stent placements.

Variables	Values
Platelet function test
PRU (SD)	187.7 (67.1)
Clopidogrel hyporesponder (No.) (%)	23 (34.8)^a
Stent type (No.) (%)
LVIS Jr	22 (33.3)
Neuroform Atlas	44 (66.7)
No. of stents (No.) (%)
1	59 (89.4)
2	7 (10.6)^b